UAB Uniqmed Pharma Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 121,048 |
| 63,376 |
| -48,620 |
| -48,620 |
| -25,455 |
| 24.08 |
| -40.17 |
| 273,670 |
| 244,322 |
| 0 |
| 517,992 |
| 2024 |
|---|
| 11,655 |
| 5,828 |
| 31,336 |
| -31,336 |
| -15,668 |
| -89.42 |
| -268.86 |
| 242,334 |
| 328,806 |
| 341,992 |
| 229,148 |
| 2025 |
|---|
| 38,206 |
| 19,103 |
| 88,220 |
| -88,220 |
| -44,110 |
| -36.44 |
| -230.91 |
| 154,114 |
| 320,423 |
| 369,787 |
| 104,316 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 38,206 |
| 19,103 |
| 88,220 |
| -88,220 |
| -44,110 |
| -36.44 |
| -230.91 |
| 154,114 |
| 320,423 |
| 369,787 |
| 104,316 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
38,206 €228 % *
Sales per employee (€)
19,103 €228 % *
Profit before tax (€)
88,220 €182 % *
Net Profit (€)
-88,220 €-182 % *
Profit per employee (€)
-44,110 €-182 % *
Total profitability (%)
-36.44 %59.25 % *
Net profitability (%)
-230.91 %14.12 % *
Equity (€)
154,114 €-36 % *
Amounts Payable And Liabilities (€)
320,423 €-3 % *
Non-current Assets (€)
369,787 €8 % *
CurrentAssets (€)
104,316 €-54 % *
